D-Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study

D. Prisco, E. Antonucci, S. Fedi, M. Margheri, C. Giglioli, M. Comeglio, A. Lombardi, M. Chioccioli, R. Abbate, G. F. Gensini

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

It has been reported that the increase of plasminogen activator inhibitor-1 activity immediately after elective coronary angioplasty is related to subsequent clinical recurrence in patients with chronic coronary artery disease. The aims of our study were to evaluate the behavior of plasminogen activator inhibitor-1 and D-Dimer after revascularization in acute myocardial infarction patients treated with angioplasty and stenting and if this behavior is predictive of subsequent clinical recurrence. D-Dimer and plasminogen activator inhibitor-1 activity were evaluated in two groups of patients. Group 1 consisted of 54 consecutive patients undergoing primary angioplasty for acute myocardial infarction and Group 2 consisted of 48 patients undergoing elective angioplasty. Patients underwent control coronary angiography only in the case of clinical recurrence and/or positivity of provocative tests. D-Dimer and plasminogen activator inhibitor-1 baseline levels were significantly higher in group 1 than in group 2 (P

Original languageEnglish
Pages (from-to)219-224
Number of pages6
JournalClinical and Experimental Medicine
Volume1
Issue number4
Publication statusPublished - 2001

Fingerprint

Plasminogen Activator Inhibitor 1
Angioplasty
Myocardial Infarction
Recurrence
Angiography
Coronary Angiography
fibrin fragment D
Coronary Artery Disease

Keywords

  • Clinical recurrence
  • D-Dimer
  • Percutaneous transluminal angioplasty
  • Plasminogen activator inhibitor-1
  • Primary revascularization
  • Stent

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Clinical Biochemistry

Cite this

D-Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study. / Prisco, D.; Antonucci, E.; Fedi, S.; Margheri, M.; Giglioli, C.; Comeglio, M.; Lombardi, A.; Chioccioli, M.; Abbate, R.; Gensini, G. F.

In: Clinical and Experimental Medicine, Vol. 1, No. 4, 2001, p. 219-224.

Research output: Contribution to journalArticle

Prisco, D, Antonucci, E, Fedi, S, Margheri, M, Giglioli, C, Comeglio, M, Lombardi, A, Chioccioli, M, Abbate, R & Gensini, GF 2001, 'D-Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study', Clinical and Experimental Medicine, vol. 1, no. 4, pp. 219-224.
Prisco, D. ; Antonucci, E. ; Fedi, S. ; Margheri, M. ; Giglioli, C. ; Comeglio, M. ; Lombardi, A. ; Chioccioli, M. ; Abbate, R. ; Gensini, G. F. / D-Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study. In: Clinical and Experimental Medicine. 2001 ; Vol. 1, No. 4. pp. 219-224.
@article{4e1c513636124ef0998946ad501a4e61,
title = "D-Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study",
abstract = "It has been reported that the increase of plasminogen activator inhibitor-1 activity immediately after elective coronary angioplasty is related to subsequent clinical recurrence in patients with chronic coronary artery disease. The aims of our study were to evaluate the behavior of plasminogen activator inhibitor-1 and D-Dimer after revascularization in acute myocardial infarction patients treated with angioplasty and stenting and if this behavior is predictive of subsequent clinical recurrence. D-Dimer and plasminogen activator inhibitor-1 activity were evaluated in two groups of patients. Group 1 consisted of 54 consecutive patients undergoing primary angioplasty for acute myocardial infarction and Group 2 consisted of 48 patients undergoing elective angioplasty. Patients underwent control coronary angiography only in the case of clinical recurrence and/or positivity of provocative tests. D-Dimer and plasminogen activator inhibitor-1 baseline levels were significantly higher in group 1 than in group 2 (P",
keywords = "Clinical recurrence, D-Dimer, Percutaneous transluminal angioplasty, Plasminogen activator inhibitor-1, Primary revascularization, Stent",
author = "D. Prisco and E. Antonucci and S. Fedi and M. Margheri and C. Giglioli and M. Comeglio and A. Lombardi and M. Chioccioli and R. Abbate and Gensini, {G. F.}",
year = "2001",
language = "English",
volume = "1",
pages = "219--224",
journal = "Zeitschrift für Die Gesamte Experimentelle Medizin",
issn = "1591-8890",
publisher = "Springer-Verlag Italia",
number = "4",

}

TY - JOUR

T1 - D-Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study

AU - Prisco, D.

AU - Antonucci, E.

AU - Fedi, S.

AU - Margheri, M.

AU - Giglioli, C.

AU - Comeglio, M.

AU - Lombardi, A.

AU - Chioccioli, M.

AU - Abbate, R.

AU - Gensini, G. F.

PY - 2001

Y1 - 2001

N2 - It has been reported that the increase of plasminogen activator inhibitor-1 activity immediately after elective coronary angioplasty is related to subsequent clinical recurrence in patients with chronic coronary artery disease. The aims of our study were to evaluate the behavior of plasminogen activator inhibitor-1 and D-Dimer after revascularization in acute myocardial infarction patients treated with angioplasty and stenting and if this behavior is predictive of subsequent clinical recurrence. D-Dimer and plasminogen activator inhibitor-1 activity were evaluated in two groups of patients. Group 1 consisted of 54 consecutive patients undergoing primary angioplasty for acute myocardial infarction and Group 2 consisted of 48 patients undergoing elective angioplasty. Patients underwent control coronary angiography only in the case of clinical recurrence and/or positivity of provocative tests. D-Dimer and plasminogen activator inhibitor-1 baseline levels were significantly higher in group 1 than in group 2 (P

AB - It has been reported that the increase of plasminogen activator inhibitor-1 activity immediately after elective coronary angioplasty is related to subsequent clinical recurrence in patients with chronic coronary artery disease. The aims of our study were to evaluate the behavior of plasminogen activator inhibitor-1 and D-Dimer after revascularization in acute myocardial infarction patients treated with angioplasty and stenting and if this behavior is predictive of subsequent clinical recurrence. D-Dimer and plasminogen activator inhibitor-1 activity were evaluated in two groups of patients. Group 1 consisted of 54 consecutive patients undergoing primary angioplasty for acute myocardial infarction and Group 2 consisted of 48 patients undergoing elective angioplasty. Patients underwent control coronary angiography only in the case of clinical recurrence and/or positivity of provocative tests. D-Dimer and plasminogen activator inhibitor-1 baseline levels were significantly higher in group 1 than in group 2 (P

KW - Clinical recurrence

KW - D-Dimer

KW - Percutaneous transluminal angioplasty

KW - Plasminogen activator inhibitor-1

KW - Primary revascularization

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=18344392053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18344392053&partnerID=8YFLogxK

M3 - Article

C2 - 11918281

AN - SCOPUS:18344392053

VL - 1

SP - 219

EP - 224

JO - Zeitschrift für Die Gesamte Experimentelle Medizin

JF - Zeitschrift für Die Gesamte Experimentelle Medizin

SN - 1591-8890

IS - 4

ER -